We are live on ! Find out more
ENTX icon

Entera Bio

12 hedge funds and large institutions have $1.87M invested in Entera Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 8.92%8.95% (+0.03%)

0% more funds holding

Funds holding: 1212 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

14% less capital invested

Capital invested by funds: $2.17M → $1.87M (-$296K)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
3
Reduced
3
Closed
3
Calls
$29K
Puts
Net Calls
+$29K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
KCM
1
Knoll Capital Management
Florida
$1.8M
Renaissance Technologies
2
Renaissance Technologies
New York
$17K +$5.38K +7,300 +45%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$12.8K
Citadel Advisors
4
Citadel Advisors
Florida
$11.1K +$11.3K +15,336 +47,925%
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$9.43K +$2.21K +3,000 +30%
HighTower Advisors
6
HighTower Advisors
Illinois
$9K
Millennium Management
7
Millennium Management
New York
$8.25K +$8.38K +11,374 New
Morgan Stanley
8
Morgan Stanley
New York
$725 -$74 -100 -9%
UBS Group
9
UBS Group
Switzerland
$445 -$331 -450 -42%
Group One Trading
10
Group One Trading
Illinois
$250 +$254 +345 New
SCA
11
Stonebridge Capital Advisors
Minnesota
$145 +$147 +200 New
HF
12
HRT Financial
New York
-$22K -26,414 Closed
Osaic Holdings
13
Osaic Holdings
Arizona
-$633 -750 Closed
Simplex Trading
14
Simplex Trading
Illinois
-$10 -13 -13%

ENTX Hedge Fund Activity: Q3 2023 in Review

12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2023, worth a combined $1.87M — down 14% from $2.17M a quarter earlier.

Fund positioning in ENTX was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $11.3K. The largest seller was HRT Financial, exiting entirely with an estimated $22K sold.

  • 12 institutional investors held Entera Bio (ENTX) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $1.87M of Entera Bio stock for Q3 2023, down 14% quarter-over-quarter.
  • 3 funds opened new Entera Bio positions in Q3 2023 and 3 closed out, a net change of 0 holders.
  • The largest Entera Bio buyer in Q3 2023 was Citadel Advisors, an estimated $11.3K added.
  • The largest Entera Bio seller in Q3 2023 was HRT Financial, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2023.